Cargando…
Framework conditions facilitating paediatric clinical research
The use of unlicensed and "off-label" medicines in children is widespread. Between 50-80% of the medicines currently administered to children have neither been tested nor authorized for their use in the paediatric population which represents approximately 25% of the whole European populati...
Autores principales: | , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3055809/ https://www.ncbi.nlm.nih.gov/pubmed/21345195 http://dx.doi.org/10.1186/1824-7288-37-12 |
_version_ | 1782200140545654784 |
---|---|
author | Knellwolf, Anne-Laure Bauzon, Stéphane Alberighi, Ornella Della Casa Lutsar, Irja Bácsy, Ernö Alfarez, Deborah Panei, Pietro |
author_facet | Knellwolf, Anne-Laure Bauzon, Stéphane Alberighi, Ornella Della Casa Lutsar, Irja Bácsy, Ernö Alfarez, Deborah Panei, Pietro |
author_sort | Knellwolf, Anne-Laure |
collection | PubMed |
description | The use of unlicensed and "off-label" medicines in children is widespread. Between 50-80% of the medicines currently administered to children have neither been tested nor authorized for their use in the paediatric population which represents approximately 25% of the whole European population. On 26 January 2007, entered into force the European Regulation of Paediatric Medicines. It aims at the quality of research into medicines for children but without subjecting the paediatric population to unnecessary clinical trial. This article addresses ethical and legal issues arising from the regulation and makes recommendations for the framework conditions facilitating the development of clinical research with children. |
format | Text |
id | pubmed-3055809 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-30558092011-03-12 Framework conditions facilitating paediatric clinical research Knellwolf, Anne-Laure Bauzon, Stéphane Alberighi, Ornella Della Casa Lutsar, Irja Bácsy, Ernö Alfarez, Deborah Panei, Pietro Ital J Pediatr Review The use of unlicensed and "off-label" medicines in children is widespread. Between 50-80% of the medicines currently administered to children have neither been tested nor authorized for their use in the paediatric population which represents approximately 25% of the whole European population. On 26 January 2007, entered into force the European Regulation of Paediatric Medicines. It aims at the quality of research into medicines for children but without subjecting the paediatric population to unnecessary clinical trial. This article addresses ethical and legal issues arising from the regulation and makes recommendations for the framework conditions facilitating the development of clinical research with children. BioMed Central 2011-02-23 /pmc/articles/PMC3055809/ /pubmed/21345195 http://dx.doi.org/10.1186/1824-7288-37-12 Text en Copyright ©2011 Knellwolf et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Knellwolf, Anne-Laure Bauzon, Stéphane Alberighi, Ornella Della Casa Lutsar, Irja Bácsy, Ernö Alfarez, Deborah Panei, Pietro Framework conditions facilitating paediatric clinical research |
title | Framework conditions facilitating paediatric clinical research |
title_full | Framework conditions facilitating paediatric clinical research |
title_fullStr | Framework conditions facilitating paediatric clinical research |
title_full_unstemmed | Framework conditions facilitating paediatric clinical research |
title_short | Framework conditions facilitating paediatric clinical research |
title_sort | framework conditions facilitating paediatric clinical research |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3055809/ https://www.ncbi.nlm.nih.gov/pubmed/21345195 http://dx.doi.org/10.1186/1824-7288-37-12 |
work_keys_str_mv | AT knellwolfannelaure frameworkconditionsfacilitatingpaediatricclinicalresearch AT bauzonstephane frameworkconditionsfacilitatingpaediatricclinicalresearch AT alberighiornelladellacasa frameworkconditionsfacilitatingpaediatricclinicalresearch AT lutsarirja frameworkconditionsfacilitatingpaediatricclinicalresearch AT bacsyerno frameworkconditionsfacilitatingpaediatricclinicalresearch AT alfarezdeborah frameworkconditionsfacilitatingpaediatricclinicalresearch AT paneipietro frameworkconditionsfacilitatingpaediatricclinicalresearch |